TAMPA, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC, founded in 1994, is a large national nonprofit in the Health Care sector that reported $2.0B in total revenue in fiscal year 2022. Revenue grew 15% year-over-year, indicating healthy expansion. The organization ran a surplus of $402.3M, a strong 20% operating margin.
THE PRIMARY PURPOSE OF THE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. ("HOSPITAL") IS TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER.
H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL, INC. (THE "HOSPITAL") IS LOCATED ON THE CAMPUS OF THE UNIVERSITY OF SOUTH FLORIDA IN TAMPA, FL. SINCE OPENING IN 1986, THE HOSPITAL HAS...
H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE HOSPITAL, INC. (THE "HOSPITAL") IS LOCATED ON THE CAMPUS OF THE UNIVERSITY OF SOUTH FLORIDA IN TAMPA, FL. SINCE OPENING IN 1986, THE HOSPITAL HAS BEEN GUIDED BY ONE MISSION, "TO CONTRIBUTE TO THE PREVENTION AND CURE OF CANCER." MOFFITT IS A LEADING NATIONAL CANCER INSTITUTE (NCI) COMPREHENSIVE CANCER CENTER - ONE OF ONLY 49 IN THE NATION TO HOLD THIS DISTINCTION. MOFFITT IS A TOP 10 CANCER HOSPITAL AND HAS BEEN NATIONALLY RANKED BY U.S. NEWS & WORLD REPORT SINCE 1999. WITH MORE THAN 9,000 EMPLOYEES, MOFFITT HAS AN ECONOMIC IMPACT ON FLORIDA OF $2.4 BILLION.RESEARCH IS CRITICAL TO MOFFITT'S MISSION. MUCH OF OUR CLINICAL TRIALS AND STUDIES ARE DONE THROUGH COLLABORATION BETWEEN MOFFITT RESEARCHERS AND PHYSICIANS WHO FOCUS ON COMPREHENSIVE CANCER TREATMENT.THE CLINICAL TRIALS AND STUDIES EXPLORE NEW MEDICAL DISCOVERIES OR NEW WAYS TO USE EXISTING TREATMENTS TO IMPROVE PATIENT CARE. EVERY PARTICIPANT HELPS TAKE US ONE STEP CLOSER TO THAT NEXT BIG BREAKTHROUGH IN CANCER TREATMENT.REIMBURSEMENT IS ALSO CRITICAL TO THE HOSPITAL'S OPERATIONS; HOWEVER, MOFFITT RECOGNIZES ITS RESPONSIBILITY TO PROVIDE SERVICES AND EDUCATION TO THOSE NEEDING SPECIALIZED RESEARCH CAPABILITIES. PATIENTS WHO MEET MOFFITT'S MEDICAL AND SURGICAL PROTOCOLS AND DO NOT HAVE THE ABILITY TO PAY WILL BE TREATED, IF SUCH PROTOCOLS ARE NOT AVAILIABLE IN THEIR COMMUNITY.IT IS THIS COMMITTMENT THAT GUIDES THE HOSPITAL TO:1) PROVIDE CARE FOR PATIENTS COVERED BY GOVERNMENTAL PROGRAMS BELOW COST2) PROVIDE FREE CHARITY CARE FOR THOSE WHO CANNOT PAY3) PROVIDE ONCOLOGY SPECIALIZATION TO THE STATE OF FLORIDA THROUGH INVOLVEMENT IN INVESTIGATIONAL PROTOCOLS, EDUCATION OF FUTURE PHYSICIANS AND CONTINUING PROFESSIONAL EDUCATION FOR PHYSICIANS AND OTHER ALLIED HEALTH CARE PROFESSIONALS4) TAKE A LEADERSHIP ROLE IN CANCER PREVENTION AND SCREENING ACTIVITIES THE HOSPITAL IS A CRITICAL RESOURCE FOR THE STATE OF FLORIDA, WHICH RANKS SECOND IN THE NATION IN BOTH CANCER INCIDENCE AND MORTALITY. MOFFITT IS LICENSED FOR 218 BEDS AND DEVOTES MORE THAN 2 MILLION SQUARE FEET TO RESEARCH AND PATIENT CARE. ADDITIONALLY, MOFFITT PROVIDES A WIDE ARRAY OF OUTREACH AND EDUCATIONAL ACTIVITIES FOR THE GENERAL PUBLIC AND SELECT UNDERSERVED POPULATIONS. IN FISCAL YEAR 2023, THE HOSPITAL RECORDED 618,616 OUTPATIENT VISITS AND 10,961 ADMISSIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $2,024,751,052 | $1,753,776,154 | +0.2% |
| Expenses | $1,622,473,343 | $1,409,693,924 | +0.2% |
| Net Income | $402,277,709 | $344,082,230 | +0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BETH A HOUGHTON | DIRECTOR, CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| THE HON MARK A PIZZO ESQ | DIRECTOR, VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOSEPH CABALLERO | DIRECTOR, SEC/TREAS | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BETH SIMONETTI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HAL WALKER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JACQUELINE LEWIS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER MOFFITT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KEVIN PLUMMER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LANSING SCRIVEN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARY ANNE REILLY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL BICE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NICOLAS PORTER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RENEE THOMPSON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT HORTON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROLAND DANIELS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| VALERIE GODDARD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SARABDEEP SINGH | HOSPITAL PRESIDENT | 25.00 |
Officer
|
$0 | $89,732 | $708,652 |
| ROBERT KEENAN | VP-QUALITY/CMO | 55.00 |
Officer
|
$750,701 | $-82,673 | $668,028 |
| G DOUGLAS LETSON | EVP-PHYS IN CHIEF | 15.00 |
Officer
|
$838,552 | $-245,481 | $593,071 |
| JANE FUSILERO | VP-PATIENT CARE SVS/CNO TO 2/5/23 | 55.00 |
Officer
|
$496,976 | $353 | $497,329 |
| YVETTE M LYONS TREMONTI | EVP-CFAO & ASST TREASURER | 20.00 |
Officer
|
$0 | $-345,650 | $478,620 |
| HENRY REYES | VP-PARTNERSHIP DEVELOPMENT | 10.00 |
Officer
|
$0 | $45,443 | $386,293 |
| JOANNA WEISS | SVP FINANCE | 15.00 |
Officer
|
$0 | $-91,001 | $357,835 |
| EVAN ZASLOW | VP PAYER STRATEGIES AS OF 8/1/22 | 18.00 |
Officer
|
$330,341 | $27,425 | $357,766 |
| MATTHEW BEDNAR | VP-AMBULATORY/VIRTUAL CARE OPS | 55.00 |
Officer
|
$341,487 | $5,574 | $347,061 |
| L DAVID DE LA PARTE | EVP-GENERAL COUNSEL; ASST SEC | 20.00 |
Officer
|
$0 | $-330,860 | $343,839 |
| TERRENCE WRIGHT | VP-FAC & SUP SVCS | 25.00 |
Officer
|
$0 | $45,739 | $340,142 |
| KEN KOMORNY | VP CHIEF PHARM OFF AS OF 9/4/22 | 25.00 |
Officer
|
$271,110 | $38,704 | $309,814 |
| KELLY GONZALVO | VP PATIENT CARE/CNO AS OF 2/5/23 | 55.00 |
Officer
|
$216,304 | $16,144 | $232,448 |
| MARILYN COSTACHE | CHIEF RISK OFFICER | 55.00 |
Officer
|
$78,014 | $16,565 | $206,109 |
| BRYAN MCIVER | DEPUTY PHYSICIAN IN CHIEF | 50.00 |
Highest
|
$606,810 | $-30,302 | $576,508 |
| EDUARDO G MOROS | SR MBR PHYSICIST-RAD ONC | 50.00 |
Highest
|
$382,910 | $-119,566 | $263,344 |
| KAREN WARTENBERG | VP MOFFITT MEDICAL GROUP | 30.00 |
Highest
|
$369,715 | $-188,061 | $181,654 |
| STUART G WASSERMAN | DIR CLINICAL PHYSICS | 50.00 |
Highest
|
$303,237 | $-163,795 | $139,442 |
| GEOFFREY G ZHANG | SR MBR PHYSICIST-RAD ONC | 50.00 |
Highest
|
$307,110 | $-220,485 | $86,625 |
| PATRICK HWU | FRM HOSPITAL PRESIDENT TO 10/31/21 | 10.00 |
|
$0 | $102,275 | $1,263,866 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $2,024,751,052 | $1,622,473,343 | $392,759,623 | $402,277,709 |
| 2022 | $1,753,776,154 | $1,409,693,924 | $351,948,718 | $344,082,230 |
| 2021 | $1,529,253,212 | $1,233,194,674 | $306,961,963 | $296,058,538 |
| 2020 | $1,369,161,087 | $1,080,580,709 | $286,006,622 | $288,580,378 |
| 2019 | $1,262,183,814 | $1,017,284,444 | $274,999,134 | $244,899,370 |
| 2018 | $1,042,592,797 | $874,970,844 | $215,935,906 | $167,621,953 |
Compare H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL INC with other nonprofits in Florida and across the country.